There are a number of tumor‐promoting factors in tumor cells such as IL‐17RB, IGF‐1R, MDR1, Bcl‐2, and HMGA2, among others, that can mediate resistance of cancer cells to DOX chemotherapy. Here, IGF1R is linked to neoplasm.